Clinical trial
Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent…
NCT00136786 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00136786 |
|---|---|
| Title | Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3 |
| Official title | Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tobacco Use Disorder |
| Intervention type | Drug |
| Interventions | Memantine |
| Enrollment | 25 |
| Start date | Dec 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Aug 29, 2005 |
| Last update posted | May 21, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: